Cargando…

Quality of life in purely ocular myasthenia in Japan

BACKGROUND: Since there has been no conclusive evidence regarding the treatment of ocular myasthenia, treatment guidelines were recently issued by the European Federation of Neurological Societies/European Neurological Society (EFNS/ENS). However, the therapeutic outcomes concerning the quality-of-l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Suzuki, Shigeaki, Murai, Hiroyuki, Imai, Tomihiro, Nagane, Yuriko, Masuda, Masayuki, Tsuda, Emiko, Konno, Shingo, Oji, Satoru, Nakane, Shunya, Motomura, Masakatsu, Suzuki, Norihiro, Utsugisawa, Kimiaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4088302/ https://www.ncbi.nlm.nih.gov/pubmed/24996227 http://dx.doi.org/10.1186/1471-2377-14-142

Ejemplares similares

Association between Glucocorticoid-Induced Osteoporosis and Myasthenia Gravis: A Cross-Sectional Study
por: Konno, Shingo, et al.
Publicado: (2015)

Reappraisal of Oral Steroid Therapy for Myasthenia Gravis
por: Imai, Tomihiro, et al.
Publicado: (2020)

Insights into the Classification of Myasthenia Gravis
por: Akaishi, Tetsuya, et al.
Publicado: (2014)

Response to treatment of myasthenia gravis according to clinical subtype
por: Akaishi, Tetsuya, et al.
Publicado: (2016)

Early fast‐acting treatment strategy against generalized myasthenia gravis
por: Utsugisawa, Kimiaki, et al.
Publicado: (2017)

Three Types of Striational Antibodies in Myasthenia Gravis
por: Suzuki, Shigeaki, et al.
Publicado: (2011)

Oral corticosteroid dosing regimen and long-term prognosis in generalised myasthenia gravis: a multicentre cross-sectional study in Japan
por: Imai, Tomihiro, et al.
Publicado: (2018)

Social disadvantages associated with myasthenia gravis and its treatment: a multicentre cross-sectional study
por: Nagane, Yuriko, et al.
Publicado: (2017)

Headache Associated with Myasthenia Gravis: The Impact of Mild Ocular Symptoms
por: Nishimoto, Yoshinori, et al.
Publicado: (2011)

Factors associated with depressive state in patients with myasthenia gravis: a multicentre cross-sectional study
por: Suzuki, Yasushi, et al.
Publicado: (2011)

Analysis of peripheral B cells and autoantibodies against the anti-nicotinic acetylcholine receptor derived from patients with myasthenia gravis using single-cell manipulation tools
por: Makino, Tomohiro, et al.
Publicado: (2017)

Safety and effectiveness of eculizumab in Japanese patients with generalized myasthenia gravis: interim analysis of post-marketing surveillance
por: Murai, Hiroyuki, et al.
Publicado: (2021)

Cytometric cell-based assays for anti-striational antibodies in myasthenia gravis with myositis and/or myocarditis
por: Kufukihara, Kenji, et al.
Publicado: (2019)

Response to eculizumab in patients with myasthenia gravis recently treated with chronic IVIg: a subgroup analysis of REGAIN and its open-label extension study
por: Jacob, Saiju, et al.
Publicado: (2020)

Immune checkpoint inhibitors in the onset of myasthenia gravis with hyperCKemia
por: Takamatsu, Koutaro, et al.
Publicado: (2018)

Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic
por: Jacob, Saiju, et al.
Publicado: (2020)

Myasthenia Gravis
por: Aarli, Johan A., et al.
Publicado: (2011)

New onset of myasthenia gravis after intravesical Bacillus Calmette-Guerin: A case report and literature review
por: Takizawa, Tsubasa, et al.
Publicado: (2017)

COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)
por: Muppidi, Srikanth, et al.
Publicado: (2020)

Suitable indications of eculizumab for patients with refractory generalized myasthenia gravis
por: Oyama, Munenori, et al.
Publicado: (2020)

Immunotherapy for ocular myasthenia gravis: an observational study in Japan
por: Narita, Tomoko, et al.
Publicado: (2023)

Long‐term safety and efficacy of eculizumab in generalized myasthenia gravis
por: Muppidi, Srikanth, et al.
Publicado: (2019)

Anemia in female patients with myasthenia gravis
por: Sekiguchi, Koji, et al.
Publicado: (2022)

Flare of myasthenia gravis induced by COVID-19 vaccines
por: Ishizuchi, Kei, et al.
Publicado: (2022)

Eculizumab improved weakness and taste disorder in thymoma-associated generalized myasthenia gravis with anti-striational antibodies: A case report
por: Amano, Eiichiro, et al.
Publicado: (2019)

Pure red cell aplasia and seronegative myasthenia gravis in association with thymoma
por: Lee, Sun Yong, et al.
Publicado: (2020)

Simultaneous pembrolizumab-induced myasthenia gravis and myocarditis in a patient with metastatic bladder cancer: A case report
por: Takai, Manabu, et al.
Publicado: (2020)

Pembrolizumab-induced Ocular Myasthenia Gravis with Anti-titin Antibody and Necrotizing Myopathy
por: Onda, Asako, et al.
Publicado: (2019)

Myasthenia Gravis Complicated by Eosinophilic Granulomatosis with Polyangiitis: A Case Report
por: Uchi, Takahumi, et al.
Publicado: (2022)

Anti-MuSK Antibody-positive Myasthenia Gravis Successfully Treated with Outpatient Periodic Weekly Blood Purification Therapy
por: Deguchi, Kentaro, et al.
Publicado: (2018)

Prediction of the generalization of myasthenia gravis with purely ocular symptoms at onset: a multivariable model development and validation
por: Li, Feng, et al.
Publicado: (2022)

The Course of Incidental Intraorbital Cavernous Hemangioma in a Patient with Myasthenia Gravis Treated with Cyclosporine: A Case Report
por: Konno, Shingo, et al.
Publicado: (2014)

Novel 3-D action video game mechanics reveal differentiable cognitive constructs in young players, but not in old
por: Ono, Tomihiro, et al.
Publicado: (2022)

Human Leucocyte Antigen B50 Is Associated with Conversion to Generalized Myasthenia Gravis in Patients with Pure Ocular Onset
por: Tiftikcioglu, Bedile Irem, et al.
Publicado: (2017)

Lack of Immunotherapy as the Only Predictor of Secondary Generalization in Very-Late-Onset Myasthenia Gravis With Pure Ocular Onset
por: Zhao, Sijia, et al.
Publicado: (2022)

Surgical treatment for medically refractory myasthenic blepharoptosis
por: Shimizu, Yusuke, et al.
Publicado: (2014)

Transient receptor potential vanilloid 1-immunoreactive signals in murine enteric glial cells
por: Yamamoto, Masahiro, et al.
Publicado: (2016)

Experimental autoimmune myasthenia gravis and CD5+ B-lymphocyte expression.
por: Lee, K. W., et al.
Publicado: (1999)

Effects of an evidence-based medicine workshop on Japanese pharmacy students’ awareness regarding the importance of reading current clinical literature
por: Nakagawa, Naoto, et al.
Publicado: (2015)

Thymic carcinoma with myasthenia gravis: Two case reports
por: Kurihara, Nobuyasu, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0imoh97dhqfr7l6l5946a55o04